Discovery of a fusion kinase in EOL-1 cells and idiopathic hypereosinophilic syndrome

Proceedings of the National Academy of Sciences of the United States of America

Volumn 100, Issue 13, 2003, Pages 7830-7835

  Griffin, John H ^a   Leung, Joey ^a   Bruner, Rebecca J ^b   Caligiuri, Michael A ^b   Briesewitz, Roger ^a,b  

^a THERAVANCE INC   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DIMETHYL 5 (2 OXO 1H INDOL 3 YLMETHYLENE) 3 PYRROLEPROPIONIC ACID; BCR ABL PROTEIN; HYBRID PROTEIN; IMATINIB; PIPERAZINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR INHIBITOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; THRX 165724; UNCLASSIFIED DRUG; VATALANIB;

ADULT; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL MODEL; ARTICLE; BLOOD CELL; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CELL LINE; CELL PROLIFERATION; CELL STRAIN EOL 1; CELL VIABILITY; CHROMOSOME 4Q; CHRONIC MYELOID LEUKEMIA; EXON; FUSION GENE; HUMAN; HUMAN CELL; HYPEREOSINOPHILIC SYNDROME; MALE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; EOSINOPHILS; GENE DELETION; HUMANS; HYPEREOSINOPHILIC SYNDROME; INDOLES; MALE; MICE; MODELS, CHEMICAL; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PEPTIDES; PHTHALAZINES; PIPERAZINES; PRECIPITIN TESTS; PROTEIN STRUCTURE, TERTIARY; PYRIDINES; PYRIMIDINES; PYRROLES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECOMBINANT FUSION PROTEINS; RECURRENCE; TYROSINE;

ANIMALIA;

EID: 0037596569     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0932698100     Document Type: Article

References (30)

1. Bain, B. J. (2000) Curr. Opin. Hematol. 7, 21-25.
2. Gleich, G. J., Leiferman, K. M., Pardanani, A., Tefferi, A. & Butterfield, J. H. (2002) Lancet 359, 1577-1578.
3. Pardanani, A. D., Reeder, T. L., Porrata, L. F., Li, C. Y., Tazelaar, H. D., Baxter, E. J., Witzig, T. E., Cross, N. C. & Tefferi, A. (2002) Blood 101, 3391-3397.
4. Ault, P., Cortes, J., Koller, C., Kaled, E. S. & Kantarjian, H. (2002) Leuk. Res. 26, 881-884.
5. Schaller, J. L. & Burkland, G. A. (2001) MedGenMed 3, 9.
6. Druker, B. J., Talpaz, M., Resta, D. J., Peng, B., Buchdunger, E., Ford, J. M., Lydon, N. B., Kantarjian, H., Capdeville, R., Ohno-Jones, S., et al. (2001) N. Engl. J. Med. 344, 1031-1037.
7. Druker, B. J., Sawyers, C. L., Kantarjian, H., Resta, D. J., Reese, S. F., Ford, J. M., Capdeville, R. & Talpaz, M. (2001) N. Engl. J. Med. 344, 1038-1042.
8. Apperley, J. F., Gardembas, M., Melo, J. V., Russell-Jones, R., Bain, B. J., Baxter, E. J., Chase, A., Chessells, J. M., Colombat, M., Dearden, C. E., et al. (2002) N. Engl. J. Med. 347, 481-487.
9. Heinrich, M. C., Corless, C. L., Duensing, A., McGreevey, L., Chen, C. J., Joseph, N., Singer, S., Griffith, D. J., Haley, A., Town, A., et al. (2003) Science 299, 708-710.
10. Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) N. Engl. J. Med. 347, 472-480.
11. Bold, G., Altmann, K. H., Frei, J., Lang, M., Manley, P. W., Traxler, P., Wietfeld, B., Bruggen, J., Buchdunger, E., Cozens, R., et al. (2000) J. Med. Chem. 43, 2310-2323.
12. Sun, L., Tran, N., Liang, C., Tang, F., Rice, A., Schreck, R., Waltz, K., Shawver, L. K., McMahon, G. & Tang, C. (1999) J. Med. Chem. 42, 5120-5130.
13. Buchdunger, E., Cioffi, C. L., Law, N., Stover, D., Ohno-Jones, S., Druker, B. J. & Lydon, N. B. (2000) J. Pharmacol. Exp. Ther. 295, 139-145.
14. Wood, J. M., Bold, G., Buchdunger, E., Cozens, R., Ferrari, S., Frei, J., Hofmann, F., Mestan, J., Mett, H., O'Reilly, T., et al. (2000) Cancer Res. 60, 2178-2189.
15. Kawagishi, J., Kumabe, T., Yoshimoto, T. & Yamamoto, T. (1995) Genomics 30, 224-232.
16. Schindler, T., Bornmann, W., Pellicena, P., Miller, W. T., Clarkson, B. & Kuriyan, J. (2000) Science 289, 1938-1942.
17. Gorre, M. E., Mohammed, M., Ellwood, K., Hsu, N., Paquette, R., Rao, P. N. & Sawyers, C. L. (2001) Science 293, 876-880.
18. Branford, S., Rudzki, Z., Walsh, S., Grigg, A., Arthur, C., Taylor, K., Herrmann, R., Lynch, K. P. & Hughes, T. P. (2002) Blood 99, 3472-3475.
19. Duell, T., Mittermuller, J., Schmetzer, H. M., Kolb, H. J. & Wilmanns, W. (1997) Cancer Genet. Cytogenet. 94, 91-94.
20. Schoffski, P., Ganser, A., Pascheberg, U., Busche, G., Gaede, B. & Hertenstein, B. (2000) Ann. Hematol. 79, 95-98.
21. Preker, P. J., Lingner, J., Minvielle-Sebastia, L. & Keller, W. (1995) Cell 81, 379-389.
22. Matsui, T., Heidaran, M., Miki, T., Popescu, N., La Rochelle, W., Kraus, M., Pierce, J. & Aaronson, S. (1989) Science 243, 800-804.
23. Golub, T. R., Barker, G. F., Lovett, M. & Gilliland, D. G. (1994) Cell 77, 307-316.
24. Magnusson, M. K., Meade, K. E., Brown, K. E., Arthur, D. C., Krueger, L. A., Barrett, A. J. & Dunbar, C. E. (2001) Blood 98, 2518-2525.
25. Ross, T. S., Bernard, O. A., Berger, R. & Gilliland, D. G. (1998) Blood 91, 4419-4426.
26. Abe, A., Emi, N., Tanimoto, M., Terasaki, H., Marunouchi, T. & Saito, H. (1997) Blood 90, 4271-4277.
27. Kulkarni, S., Heath, C., Parker, S., Chase, A., Iqbal, S., Pocock, C. F., Kaeda, J., Cwynarski, K., Goldman, J. M. & Cross, N. C. (2000) Cancer Res. 60, 3592-3598.
28. Schwaller, J., Anastasiadou, E., Cain, D., Kutok, J., Wojiski, S., Williams, I. R., LaStarza, R., Crescenzi, B., Sternberg, D. W., Andreasson, P., et al. (2001) Blood 97, 3910-3918.
29. Baxter, E. J., Hochhaus, A., Bolufer, P., Reiter, A., Fernandez, J. M., Senent, L., Cervera, J., Moscardo, F., Sanz, M. A. & Cross, N. C. (2002) Hum. Mol. Genet. 11, 1391-1397.
30. Cools, J., DeAngelo, D., Gotlib, J., Stover, E. H., Legare, R. D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J. D., et al. (2003) N. Engl. J. Med. 348, 1201-1214.